Latest Assay Technology News

Chrysos Corporation Limited reported a robust 1H FY26 with revenue up 49% and EBITDA soaring 152%, driven by expanding adoption of its PhotonAssay technology and strategic global deployments.

Waratah Minerals has reported outstanding high-grade gold drilling results at its Spur Gold Project in New South Wales, extending mineralisation and boosting confidence in the geological model. Significant intercepts include 42m at 2.95g/t Au and a standout 1m hit at 146g/t Au.

Pantoro Gold's latest drilling at the Scotia Underground Mine reveals high-grade gold mineralisation extending 135 metres below current resources, reinforcing the mine's long-term potential within the Norseman Gold Project.

PC Gold’s re-assay program using advanced Photon Assay technology has confirmed a significant 55.5% uplift in gold grades at its Spring Hill project, challenging historical estimates and setting the stage for a resource upgrade.

CSIRO has sold about half its shares in Chrysos Corporation through a block trade, reducing its stake by roughly 9%, yet remains a committed substantial shareholder with a six-month escrow on its retained shares.

Chrysos Corporation reports nearly one million monthly PhotonAssay samples and reiterates strong FY26 revenue guidance, while unveiling next-gen assay technologies and global expansion plans.

Manuka Resources has revised its exploration target disclosures to comply with JORC standards and announced an accelerated gold drilling program targeting extensions at Mt Boppy and shallow mineralisation at Pipeline Ridge, with results expected early 2026.

Waratah Minerals reports significant new gold intercepts at its Spur and Consols Zones, expanding the promising Spur Gold Corridor in NSW. The company also accelerates exploration with more rigs and advanced assay technology.

Waratah Minerals has extended gold mineralisation by 160 metres in both directions at the Consols Zone within its Spur Gold Corridor, revealing promising high-grade intercepts. The company is accelerating drilling efforts and adopting new assay technology to fast-track exploration.

Astral Resources reports strong initial assay results from its Theia Deposit in-fill drilling, confirming broad gold mineralisation and exceptional high-grade zones that align closely with existing resource models.

Genetic Signatures Limited reported a 63% revenue surge to $15.9 million in FY25, driven by strong Australian sales and progress in EMEA, while navigating a $20.1 million net loss and a strategic pivot towards partnerships for automated diagnostics.

Chrysos Corporation reported a strong FY25 with 46% revenue growth and key contracts signed with industry leaders, setting an optimistic tone for FY26.